{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:45:47Z","timestamp":1787237147567,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13104-016-2302-1","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T07:46:09Z","timestamp":1479800769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns"],"prefix":"10.1186","volume":"9","author":[{"given":"Marvlyn","family":"Eba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Longdoh","family":"Njunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene Njikam","family":"Mouliom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Tebit","family":"Kwenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anold Nsoh","family":"Fuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon Takop","family":"Nchanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Atashili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"2302_CR1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7241\/ourd.20123.39","volume":"3","author":"N Puri","year":"2012","unstructured":"Puri N, Kaur T. Onychomycosis: a clinical and mycological study of 75 cases. Our Dermatol Online. 2012;3:172\u20137.","journal-title":"Our Dermatol Online"},{"key":"2302_CR2","volume-title":"Editor\u2019s Joslin\u2019s diabetes mellitus","author":"LP Krall","year":"1985","unstructured":"Krall LP, Bradley RF. Editor\u2019s Joslin\u2019s diabetes mellitus. 12th ed. Philadelphia: Lea-Febiger; 1985.","edition":"12"},{"key":"2302_CR3","first-page":"10","volume":"74","author":"LE Lynch","year":"2004","unstructured":"Lynch LE, Gupta AK. Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. Cutis. 2004;74:10\u20135.","journal-title":"Cutis"},{"key":"2302_CR4","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0190-9622(08)81262-5","volume":"31","author":"R Aly","year":"1994","unstructured":"Aly R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol. 1994;31:S21\u20135.","journal-title":"J Am Acad Dermatol."},{"key":"2302_CR5","first-page":"1","volume":"4","author":"PL Salgo","year":"2003","unstructured":"Salgo PL, Daniel CR, Gupta AK, Mozena JD, Joseph SW. Onychomycosis disease management. Med Crossfire. 2003;4:1\u201317.","journal-title":"Med Crossfire"},{"key":"2302_CR6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-4362.2002.01528.x","volume":"41","author":"S Dogra","year":"2002","unstructured":"Dogra S, Kumar B, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol. 2002;41:647\u201351.","journal-title":"Int J Dermatol"},{"key":"2302_CR7","unstructured":"International Diabetes Federation. IDF diabetes. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015. http:\/\/www.diabetesatlas.org ."},{"key":"2302_CR8","unstructured":"Mycology Online. Cellotape flag preparations. http:\/\/www.mycology.adelaide.edu.au\/Laboratory_Methods\/Microscopy_Techniques_and_Stains\/cellotape.html (2016). Accessed 24 July 2016."},{"key":"2302_CR9","unstructured":"Mycology Online. Slide culture preparations. http:\/\/www.mycology.adelaide.edu.au\/Laboratory_Methods\/Microscopy_Techniques_and_Stains\/slide.html (2016). Accessed 24 July 2016."},{"key":"2302_CR10","volume-title":"Reference method for antifungal disk diffusion susceptibility testing of non-dermatophyte filamentous fungi; approved guideline. CLSI document M51-A","author":"Clinical Laboratory Standards Institute","year":"2010","unstructured":"Clinical Laboratory Standards Institute. Reference method for antifungal disk diffusion susceptibility testing of non-dermatophyte filamentous fungi; approved guideline. CLSI document M51-A. Villanova, PA: Clinical and Laboratory Standards Institute; 2010."},{"key":"2302_CR11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Elm Von","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137.","journal-title":"Lancet"},{"key":"2302_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.medmal.2004.03.004","volume":"34","author":"R Bouguerra","year":"2004","unstructured":"Bouguerra R, Essa\u00efs O, Seba\u00ef N, et al. Prevalence and clinical aspects of superficial mycosis in hospitalized diabetic patients in Tunisia. M\u00e9d Mal Infect. 2004;34:201\u20135.","journal-title":"M\u00e9d Mal Infect"},{"key":"2302_CR13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","volume":"139","author":"AK Gupta","year":"1998","unstructured":"Gupta AK, Konnikov N, MacDonald P, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139:665\u201371.","journal-title":"Br J Dermatol"},{"key":"2302_CR14","first-page":"84","volume":"18","author":"N Al-Mutairi","year":"2010","unstructured":"Al-Mutairi N, Eassa BI, Al-Rqobah DA. Clinical and mycologic characteristics of onychomycosis in diabetic patients. ADC. 2010;18:84\u201391.","journal-title":"ADC"},{"key":"2302_CR15","first-page":"100","volume":"31","author":"MS Gerami","year":"2002","unstructured":"Gerami MS, Zomorodian K, Emami M, Tarazoei B, Saadat F. Study and identification of the etiological agents of onychomycosis in Tehran, capital of Iran. Iran J Public Health. 2002;31:100\u20134.","journal-title":"Iran J Public Health"},{"key":"2302_CR16","first-page":"21","volume":"2","author":"S S\u00fcr\u00fcc\u00fco\u011flu","year":"1998","unstructured":"S\u00fcr\u00fcc\u00fco\u011flu S, \u00d6zmen B, G\u00fcnd\u00fcz K. The frequency of superficial fungal infection in patients with diabetes mellitus and its relation to level of HbAIC. Turk J Endocrinol Metab. 1998;2:21\u20133.","journal-title":"Turk J Endocrinol Metab"},{"key":"2302_CR17","first-page":"479","volume":"44","author":"M Leelavathi","year":"2013","unstructured":"Leelavathi M, Azimah MN, Kharuddin NF, Tzar MN. Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia. Southeast Asian J Trop Med Public Health. 2013;44:479\u201383.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2302_CR18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1365-4632.2012.05509.x","volume":"51","author":"S Nkondjo Minkoumou","year":"2012","unstructured":"Nkondjo Minkoumou S, Fabrizi V, Papini M. Onychomycosis in Cameroon: a clinical and epidemiological study among dermatological patients. Int J Dermatol. 2012;51:1474\u20137.","journal-title":"Int J Dermatol"},{"key":"2302_CR19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-4632.2008.03606.x","volume":"47","author":"S-J Chang","year":"2008","unstructured":"Chang S-J, Hsu S-C, Tien K-J, et al. Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus. Int J Dermatol. 2008;47:467\u201372.","journal-title":"Int J Dermatol"},{"key":"2302_CR20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2340\/00015555-0113","volume":"86","author":"DM Saunte","year":"2006","unstructured":"Saunte DM, Holgersen JB, Haedersdal M, et al. Prevalence of toe nail onychomycosis in diabetic patients. Acta Derm Venereol. 2006;86:425\u20138.","journal-title":"Acta Derm Venereol"},{"key":"2302_CR21","first-page":"217","volume":"20","author":"T Mohammad","year":"2010","unstructured":"Mohammad T, Noorbala PK. Evaluation of onychomycosis among diabetic patients of Yazd diabetic center. JPAD. 2010;20:217\u201321.","journal-title":"JPAD"},{"key":"2302_CR22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","volume":"36","author":"AK Gupta","year":"1997","unstructured":"Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists\u2019 offices in Ontario, Canada: a multicenter survey of 2001 patients. Int J Dermatol. 1997;36:783\u20137.","journal-title":"Int J Dermatol"},{"issue":"1","key":"2302_CR23","first-page":"21","volume":"2","author":"S S\u00fcheyla","year":"1998","unstructured":"S\u00fcheyla S, Bilgin \u00d6. The frequency of superficial fungal infections in patients with diabetes mellitus and its relation to the level of HbA1c. Turk J Endocrinol Metabol. 1998;2(1):21\u20133.","journal-title":"Turk J Endocrinol Metabol"},{"issue":"1","key":"2302_CR24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1468-3083.2004.00851.x","volume":"18","author":"B Sigurgeirsson","year":"2004","unstructured":"Sigurgeirsson B, Steingr\u00edmsson O. Risk factors associated with onychomycosis. J Eur Acad Dermatol Venereol. 2004;18(1):48\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2302_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1439-0507.2001.00624.x","volume":"44","author":"L Massai","year":"2001","unstructured":"Massai L, Romano C, Asta F, Signorini AM. Prevalence of dermatophytic skin and nail infections in diabetic patients. Mycoses. 2001;44:83\u20136.","journal-title":"Mycoses"},{"key":"2302_CR26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1439-0507.1991.tb00672.x","volume":"34","author":"SM Al-Sogair","year":"1991","unstructured":"Al-Sogair SM, Moawad MK, Al-Humaidan YM. Fungal infection as a cause of skin disease in the eastern province of Saudi Arabia: prevailing fungi and pattern of infection. Mycoses. 1991;34:333\u20137.","journal-title":"Mycoses"},{"key":"2302_CR27","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMcp0804878","volume":"360","author":"D Berker De","year":"2009","unstructured":"De Berker D. Clinical practice. Fungal nail disease. N Engl J Med. 2009;360:2108\u201316.","journal-title":"N Engl J Med"},{"issue":"1","key":"2302_CR28","first-page":"499","volume":"5","author":"GP Ngaba","year":"2014","unstructured":"Ngaba GP, Essomba NE, Kedy Koum DC, Njong Meledie AP, Nida M, Nko\u2019o Wo\u2019o PD, et al. Aspects des Onychomycoses chez des patients camerounais de 2011 \u00e0 2014. Rev M\u00e9d Pharm. 2014;5(1):499\u2013506.","journal-title":"Rev M\u00e9d Pharm"},{"key":"2302_CR29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0190-9622(83)70208-2","volume":"9","author":"N Zaias","year":"1983","unstructured":"Zaias N, Drachman D. A method for the determination of drug effectiveness in onychomycosis: trials with ketoconazole and griseofulvin ultramicrosize. J Am Acad Dermatol. 1983;9:912\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"2302_CR30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000249920","volume":"165","author":"O Rollman","year":"1982","unstructured":"Rollman O. Treatment of onychomycosis by partial nail avulsion and topical miconazole. Dermatology. 1982;165:54\u201361.","journal-title":"Dermatology"},{"key":"2302_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-4362.1998.00360.x","volume":"37","author":"AK Gupta","year":"1998","unstructured":"Gupta AK, De Doncker P, Scher RK, et al. Itraconazole for the treatment of onychomycosis. Int J Dermatol. 1998;37:303\u20138.","journal-title":"Int J Dermatol"},{"key":"2302_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11046-013-9655-y","volume":"176","author":"A Hryncewicz-Gw\u00f3\u017ad\u017a","year":"2013","unstructured":"Hryncewicz-Gw\u00f3\u017ad\u017a A, Kalinowska K, Plomer-Niezgoda E, Bielecki J, Jagielski T. Increase in resistance to fluconazole and itraconazole in trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure. Mycopathologia. 2013;176:49\u201355.","journal-title":"Mycopathologia"},{"key":"2302_CR33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","volume":"11","author":"BE Elewski","year":"1998","unstructured":"Elewski BE. Onychomycosis: pathogenesis, diagnosis and management. CMR. 1998;11:415\u201325.","journal-title":"CMR"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2302-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T17:19:13Z","timestamp":1568567953000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-016-2302-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1186\/s13104-016-2302-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]},"article-number":"494"}}